The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Merck/Schering Plough; Novartis; Pfizer; Regeneron; Roche Diagnostics
• Grant Support/Research Contract - Abbott; Abiomed; Amgen; Anthos Therapeutics; AstraZenca; Daiichi-Sankyo/Elil Lilly and Company; Novartis; Merck/Schering Plough; Pfizer; Regeneron; Roche Diagnostics